MAXCYTE INC. - COMMON
3.3800
26-十一月-24 15:45:00
15 分钟延时
股票
-0.2300
-6.37%
今日范围
3.3300 - 3.6100
ISIN
N/A
来源
NASDAQ
-
12 4月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 3月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 3月 2022 15:15:00 条件 Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 2月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 2月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 2月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
01 2月 2022 01:00:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results
24 1月 2022 01:30:00 条件 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
12 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter Financial Results
10 11月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Board Member Richard Douglas, PhD, Appointed Chairman of the Board
03 11月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
29 10月 2021 11:40:00 条件 Nasdaq GlobeNewswire
-
28 10月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
25 10月 2021 15:30:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Set to Join Russell 2000® Index
17 9月 2021 07:35:00 条件 Nasdaq GlobeNewswire
-
13 9月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021
02 9月 2021 07:05:00 条件 Nasdaq GlobeNewswire